Filing Flows › Jupiter Neurosciences (JUNS) › Q2 2026
Jupiter Neurosciences (JUNS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Jupiter Neurosciences (JUNS) reported revenue of $24K for the second quarter 2026 (Q2 2026) and +30% from the quarter before.
Jupiter Neurosciences, Q2 2026: revenue $24K, net loss $2.3M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24K | +30% | — |
| Operating profit | −$2.7M | — | — |
| Net earnings | −$2.3M | — | — |
| Operating cash flow | −$2.3M | — | — |
What changed
Revenue was $24K in Q2 2026, up 30% from the previous quarter.
Gross margin was 86.9%. Operating costs exceeded revenue by $2.7M, an operating margin of -11313.4%. The quarter ended with a net loss of $2.3M, wider than the previous quarter's $2.1M loss. Non-operating items added $469K, -21% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$2.3M. Non-cash charges added back $491K of share-based compensation. Working capital and other items used $512K.
Questions
What was Jupiter Neurosciences' revenue in the second quarter 2026?
Jupiter Neurosciences (JUNS) reported revenue of $24K for the second quarter 2026 (Q2 2026) and +30% from the quarter before.